CAMX:STO
Camurus AB
739,50 SEK
arrow_downward
-0,07%(-0,50) 1D
20-ноя., 17:29:43 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,81 млд
Avg. vol.
103,71 миң
Volume
71,53 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,81 млд
Avg. vol.
103,71 миң
Volume
71,53 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
News stories
From web sources and news partners
ChartMill
·
52 мүнөт мурун
S&P 500 Top Movers: Today's Biggest Gainers and Losers
Investing.com
·
28 мүнөт мурун
S&P 500 Rebound Could Be Coming as ETF Selling Nears Capitulation
Inquirer.com
·
59 мүнөт мурун
U.S. stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecamurus.com